Cargando…
Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been the subject of a number of pharmacological approaches, particularly since when this elusive mediator was identified a...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216146/ https://www.ncbi.nlm.nih.gov/pubmed/32295055 http://dx.doi.org/10.3390/ijms21082703 |